Metabolomics Analysis

Advanced metabolomics enables identification and quantification of prognostic and diagnostic biomarkers for oncology and viral diseases. Targeted and untargeted UHPLC-HRMS analyses support therapy monitoring, patient stratification, and drug mechanism studies for clinical and pharmaceutical research.

We support pharmaceutical chemists in advancing compounds from hit to lead by evaluating ADMET properties, metabolite profiles, and stability. Integrated in vitro and in vivo assays combined with UHPLC-HRMS provide critical insights into drug metabolism, distribution, and robustness under stress conditions.

We investigate how diet, supplements, and natural products influence health, with a focus on metabolic disorders. Using green extraction methods and in vitro/in vivo assays, we profile bioactive compounds and assess their health-promoting properties through advanced UHPLC-HRMS analyses.